Five things we still don’t know after yesterday’s congressional EpiPen ‘beating’
September 22, 2016 at 12:24 PM EDT
The hearing was heavy on rhetoric but light on key issues.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.